Experimental StudyMechanisms contributing to myocardial accumulation of technetium-99m Stannous pyrophosphate (cas 15578-26-4) after coronary arterial occlusion*
-
Add time:09/06/2019 Source:sciencedirect.com
The relation between the accumulation of pyrophosphate and technetium-99m in myocardium with reversible and irreversible ischemic injury was studied in dogs subjected to transitory or persistent coronary arterial occlusion. Among four dogs with coronary occlusion maintained for less than 20 minutes, none had either increased MB creatine kinase (CK)* (the “myocardial” CK isoenzyme) activity in serum or a positive 99mTc Stannous pyrophosphate (cas 15578-26-4) image. Seven dogs with coronary occlusion maintained for 30 or more minutes had elevated serum MB CK activity, and five of the seven had positive (abnormal) images. Thus, although false negative images may occur occasionally despite myocardial damage, both increased serum MB CK and abnormal images generally accompanied prolonged coronary occlusion. In contrast, ischemia without infarction was not associated with abnormal images.Both 99mTc and 32P labeled pyrophosphate were accumulated extensively and proportionally in myocardium from zones of infarction, and uptake of both tracers was comparable although modest in isolated mitochondria. Similar results were obtained after myocardial infarction in animals with induced profound leukopenia. Thus, phagocytosis of the radiopharmaceutical agent by leukocytes migrating into the infarct is not an essential mechanism accounting for uptake. These results indicate that abnormal images reflect uptake of pyrophosphate, associated with 99mTc, by irreversibly injured myocardium rather than leukocytic infiltration involved in the inflammatory response in the heart.
We also recommend Trading Suppliers and Manufacturers of Stannous pyrophosphate (cas 15578-26-4). Pls Click Website Link as below: cas 15578-26-4 suppliers
Prev:Experimental and laboratory reportValue and limitations of technetium-99m Stannous pyrophosphate (cas 15578-26-4) in the detection of acute myocardial infarction☆
Next:Clinical studyPrognostic value of a persistently positive technetium-99m Stannous pyrophosphate (cas 15578-26-4) myocardial scintigram after myocardial infarction) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical studyPrognostic value of a persistently positive technetium-99m Stannous pyrophosphate (cas 15578-26-4) myocardial scintigram after myocardial infarction09/07/2019
- Experimental and laboratory reportValue and limitations of technetium-99m Stannous pyrophosphate (cas 15578-26-4) in the detection of acute myocardial infarction☆09/05/2019
- Determination of the optimal concentrations of Stannous pyrophosphate (cas 15578-26-4) for in vivo red blood cell labelling with technetium-99m09/04/2019
- Experimental and laboratory reportTechnetium-99m Stannous pyrophosphate (cas 15578-26-4) myocardial scintigrams in pericardial disease☆09/03/2019
- NOTESStannous-Ion Quantitation in Pyrophosphate and Polyphosphate Radiopharmaceutical Kits Using Differential Pulse Polarography09/02/2019
- ReviewExploring the biological, catalytic, and magnetic properties of transition metal coordination complexes incorporating pyrophosphate09/01/2019
- Mechanistic aspects of the interaction of 99mTc in association with Stannous pyrophosphate (cas 15578-26-4) with damaged red blood cells08/31/2019
- Investigation of the interaction of hydroxyapatite with technetium in association with Stannous pyrophosphate (cas 15578-26-4)08/30/2019
- Stabilization of Stannous pyrophosphate (cas 15578-26-4) kits with gentisic acid08/29/2019
-
Health and Chemical more >